Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 5% Spironolactone Gel Nano-Formulation vs 0.1% Adapalene Gel in Acne Vulgaris
NCT07473895Phase 2Not yet recruiting
- Sponsor
- Assiut University
- Start
- Apr 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of spironolactone in acne vulgaris (2 arms), sponsored by Assiut University. Primary endpoint: Global Acne Grading System at 8 weeks. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
spironolactone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07473895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07473895.